Subscribe To
AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients
VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has approved its application for premarket approval (PMA) […] The post AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo...
Read More
Posted: Jun 16 2023, 18:47
Author Name: forextv
Views: 112582